Related Experiment Video

Updated: Jul 3, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Comparative genomic assessment of novel broad-spectrum targets for antibacterial drugs

Thomas A White1, Douglas B Kell

  • 1Department of Biology, University of York, Heslington, York YO10 5YW, UK.

Comparative and Functional Genomics
|July 17, 2008
PubMed

Insights

Researchers identified novel antimicrobial targets by analyzing protein sequences from key pathogens. tRNA methyltransferase (trmD) and translation initiation factor IF-1 (infA) show promise for developing new antibacterial drugs against resistant infections.

Area of Science:

  • Genomics
  • Microbiology
  • Drug Discovery

Background:

  • Increasing antibiotic resistance necessitates the discovery of novel drug targets.
  • Existing antibacterial drugs target a limited number of molecular pathways.
  • Identifying new targets is crucial for combating multi-drug resistant pathogens.

Purpose of the Study:

  • To identify and prioritize novel broad-spectrum antibacterial drug targets using comparative genomics.
  • To evaluate protein essentiality, sequence conservation, and host specificity across pathogens.
  • To develop a robust scoring system for ranking potential antimicrobial targets.

Main Methods:

  • Comparative genomics analysis of all protein sequences from Staphylococcus aureus, Mycobacterium tuberculosis, and Escherichia coli O157:H7.
  • Scoring and ranking proteins based on essentiality, sequence conservation, and distribution in pathogens versus eukaryotes.
  • Sensitivity analysis to assess the impact of different scoring criteria.

Main Results:

  • Several proteins demonstrated high scores across all three pathogens, indicating broad-spectrum potential.
  • tRNA methyltransferase (trmD) and translation initiation factor IF-1 (infA) were identified as highly promising novel targets.
  • The developed scoring strategy proved robust to variations in weighting criteria.

Conclusions:

  • Comparative genomics is an effective strategy for identifying novel antimicrobial targets.
  • trmD and infA represent promising candidates for the development of new antibacterial therapies.
  • The scoring methodology can be applied to other post-genomic drug discovery initiatives.

More Related Videos

Amplicon Sequencing using the Long-Read Sequencing Technologies08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays14:06

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Published on: November 12, 2012

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...